CRO Services
30 Years of Innovation in Drug Development: The Evolution of the Contract Research Organization
Since Altasciences arrived on the scene three decades ago, science and drug development have advanced significantly.
Case Study: Achieving a 505(B)(2) Regulatory Approval for Multiple NDA-Enabling Studies
Hybrid medicines are drugs based on an approved active substance (or previously approved drug) and have a different route of administration, format, strength, or indication from the original reference product.
They require approval for market authorization based on both data from the original reference medicine, and from new clinical trials on the modified version.
Case Study—Accelerating Recruitment in Renal Impairment Trials: Leveraging Specialized External Sites
7 Tips for Navigating the Complexities of In Vitro NAMs Studies
As a board-certified toxicologist and experienced Good Laboratory Practices (GLP) Consultant, I spend quite a bit of time advising on quality issues of New Approach Methodologies (NAMs) in support of toxicology programs. While these alternative methods are exciting and full of promise, they come with their own set of challenges.
STAT: Responsible AI Frees Scientists to Focus on Science
Clinical Trials Without Boundaries: Multi-Site Solutions at Altasciences
The Year in Review 2024

4 Essential Topics to Cover in Your First CRO Meeting

Top Life Science Resources for Fall 2024
There’s a lot of life science content out there, so for your convenience, we’ve curated a selection of expert insights, tips, case studies, and scientific and regulatory information. Catch up on what you might have missed below!
Top 10 Life Science Resources for Summer 2024
There’s a lot of life science content out there, which is why we’ve curated a selection of our expert insights, tips, case studies, and scientific and regulatory information for your convenience. Catch up on what you might have missed below!